Cellectis Provides Business Objectives for 2022 and Updates its Corporate Presentation
January 04, 2022 16:30 ET
|
Cellectis Inc.
NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop...
Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer
December 23, 2021 16:05 ET
|
Aeterna Zentaris Inc
– Well-established finance professional with over 20 years of experience gained in pharmaceutical, biopharma and professional services sectors TORONTO, ONTARIO, Dec. 23, 2021 (GLOBE NEWSWIRE) --...
Monthly information on share capital and company voting rights
December 06, 2021 16:30 ET
|
Cellectis Inc.
NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number of sharesin the capitalTotal number of...
Aronora Announces Clinical Data to Be Presented at the 63rd American Society of Hematology Annual Meeting
December 06, 2021 08:00 ET
|
Aronora, Inc
PORTLAND, Ore., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Aronora Inc., a clinical-stage biotechnology company developing innovative therapies for hematologic diseases, today announced that clinical data...
Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller to Board of Directors
November 17, 2021 08:30 ET
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
The University of Pittsburgh and Orange Grove Bio Establish Partnership to Develop and Commercialize Novel Therapeutics
November 17, 2021 07:00 ET
|
Orange Grove Bio
NEW YORK and PITTSBURGH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Orange Grove Bio, a preclinical drug investment and development firm, and the University of Pittsburgh today announced the establishment of...
U.S.-Based Psychedelic Healthcare VC Fund, Palo Santo, Appoints New Members to Its Advisory Board, Amid Rapid Growth in Psychedelic Sector
November 08, 2021 08:37 ET
|
Palo Santo
CHICAGO, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Palo Santo, the leading U.S.–based psychedelic investment fund, announced its advisory board, which includes some of the world’s foremost leaders in their...
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 04, 2021 16:05 ET
|
Longboard Pharmaceuticals, Inc.
Successfully completed multiple ascending dose (MAD) portion of a Phase 1 clinical trial for LP352, a potential treatment for seizures associated with a broad range of severe epilepsiesInitiating a...
Arbutus Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 04, 2021 07:30 ET
|
Arbutus Biopharma Corporation
On-track for multiple data readouts of AB-729 and AB-836 in Q4 2021 First patient dosed in Phase 2a clinical trial combining AB-729, Peg-IFNα-2a and nucleos(t)ide analog (“NA”) therapy ...
Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel
November 02, 2021 08:30 ET
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...